ACT, who were granted permission last year to conduct a human clinical trial treating Stargardt's patients with stem cells, has announced that they can procure embryonic stem cells without embryonic destruction - a positive ethical step. They state that they are also hoping to progress to the second phase of the Stargardt's specific trial in the first half of this year.
Check out the link below:
Advance Cell Technology Update
No comments:
Post a Comment